Jerard Z. Kneifati-Hayek

Jerard Z. Kneifati-Hayek

Auto-generated profile, based on publicly available information

Jerard Z. Kneifati-Hayek

Division of General Medicine Columbia University Irving Medical Center New York New York USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2025 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
ZGZehui Gu
Zehui Gu
SDSiddhant Dogra
Siddhant Dogra
MSMutita Siriruchatanon
Mutita Siriruchatanon
JKJerard Kneifati-Hayek
Jerard Kneifati-Hayek
SKStella K. Kang
Stella K. Kang

3 June 2024 in Kidney International Reports
Verified
Journal Article
Open access
JKJerard Z. Kneifati-Hayek
Jerard Z. Kneifati-Hayek
TZTeena Zachariah
Teena Zachariah
WAWooin Ahn
Wooin Ahn
AKAtlas Khan
Atlas Khan
KKKrzysztof Kiryluk
Krzysztof Kiryluk
JNJordan G. Nestor
Jordan G. Nestor
Introduction: Genomic medicine holds transformative potential for personalized nephrology care; however, its clinical integration poses challenges. Automated clinical decision support (CDS) systems in the electronic health record (EHR) offer a promising solution but have shown limited impact. This study aims to glean practical insights into nephrologists' challenges using genomic resources, informing precision nephrology decision support tools. Methods: We conducted an anonymous electronic survey among US nephrologists from January 19, 2021 to May 19, 2021, guided by the Consolidated Framework for Implementation Research. It assessed practice characteristics, genomic resource utilization, attitudes, perceived knowledge, self-efficacy, and factors influencing genetic testing decisions. Survey links were primarily shared with National Kidney Foundation members. Results: We analyzed 319 surveys, with most respondents specializing in adult nephrology. Although respondents generally acknowledged the clinical use of genomic resources, varying levels of perceived knowledge and self-efficacy were evident regarding precision nephrology workflows. Barriers to genetic testing included cost/insurance coverage and limited genomics experience. Conclusion: The study illuminates specific hurdles nephrologists face using genomic resources. The findings are a valuable contribution to genomic implementation research, highlighting the significance of developing tailored interventions to support clinicians in using genomic resources effectively. These findings can guide the future development of CDS systems in the EHR. Addressing unmet informational and workflow support needs can enhance the integration of genomics into clinical practice, advancing personalized nephrology care and improving kidney disease outcomes. Further research should focus on interventions promoting seamless precision nephrology care integration.

7 December 2023 in BMJ Quality & Safety
Verified
Journal Article
Closed access
PDF file
JKJerard Z Kneifati-Hayek
Jerard Z Kneifati-Hayek
EGElias Geist
Elias Geist
JAJo R Applebaum
Jo R Applebaum
ACAlexis K Dal Col
Alexis K Dal Col
HSHojjat Salmasian
Hojjat Salmasian
JAJason S Adelman
Jason S Adelman
Studying near-miss errors is essential to preventing errors from reaching patients. When an error is committed, it may be intercepted (near-miss) or it will reach the patient; estimates of the proportion that reach the patient vary widely. To better understand this relationship, we conducted a retrospective cohort study using two objective measures to identify wrong-patient imaging order errors involving radiation, estimating the proportion of errors that are intercepted and those that reach the patient. This study was conducted at a large integrated healthcare system using data from 1 January to 31 December 2019. The study used two outcome measures of wrong-patient orders: (1) wrong-patient orders that led to misadministration of radiation reported to the New York Patient Occurrence Reporting and Tracking System (NYPORTS) (misadministration events); and (2) wrong-patient orders identified by the Wrong-Patient Retract-and-Reorder (RAR) measure, a measure identifying orders placed for a patient, retracted and rapidly reordered by the same clinician on a different patient (near-miss events). All imaging orders that involved radiation were extracted retrospectively from the healthcare system data warehouse. Among 293 039 total eligible orders, 151 were wrong-patient orders (3 misadministration events, 148 near-miss events), for an overall rate of 51.5 per 100 000 imaging orders involving radiation placed on the wrong patient. Of all wrong-patient imaging order errors, 2% reached the patient, translating to 50 near-miss events for every 1 error that reached the patient. This proportion provides a more accurate and reliable estimate and reinforces the utility of systematic measure of near-miss errors as an outcome for preventative interventions.

28 November 2021 in Nephrology
Verified
Journal Article
Closed access
PDF file
JKJerard Kneifati‐Hayek
Jerard Kneifati‐Hayek
JHJack Huebner
Jack Huebner
AGAnne Grauer
Anne Grauer
JAJo R. Applebaum
Jo R. Applebaum
CACraig Albanese
Craig Albanese
JAJason S. Adelman
Jason S. Adelman

11 October 2026 in Autism Research
Verified
Journal Article
Open access
FCFangyi Chen
Fangyi Chen
JKJerard Kneifati‐Hayek
Jerard Kneifati‐Hayek
CZCharlotte Zelin
Charlotte Zelin
DWDa Wu
Da Wu
QNQuan M. Nguyen
Quan M. Nguyen
CWChunhua Weng
Chunhua Weng
Autism exhibits substantial phenotypic heterogeneity, yet age‐dependent variation in phenotypic profiles and onset timing remains poorly understood. We aimed to characterize stage‐specific phenotypes and temporal onset patterns of autism using longitudinal electronic health records (EHRs). We analyzed EHR data from Columbia University Irving Medical Center. Autism cases were stratified by age at diagnosis. Phenotype enrichment analyses were performed using chi‐square and Fisher's exact tests to identify phenotypes overrepresented in autism cases compared with matched controls, and temporal patterns of phenotype onset were subsequently evaluated to identify stage‐specific clinical signatures and provide insight into differences between early‐ and late‐diagnosed individuals. Among 4818 cases and 1433 phenotypes, 195 and 155 were enriched in toddlerhood and adolescence groups. Early diagnosed individuals exhibited a higher prevalence of sensory‐related conditions, greater exposure to maternal and perinatal complications than their matched controls (all ORs > 1; p < 0.01), and earlier onset of neurologic features, including coordination abnormalities and convulsions, compared with later‐diagnosed individuals. The study provides a publicly accessible resource to enrich autism‐related phenotypic profiles, uncovering notable phenotypic differences and variations in timing of phenotype onset between early‐diagnosed and later‐diagnosed individuals. These findings underscore phenotypic heterogeneity and highlight the need for age‐sensitive screening strategies. To our knowledge, this is among the first studies to jointly characterize phenotypic profiles and their temporal onset patterns across developmental stages in autism using longitudinal EHR data. These findings offer novel insights into age‐dependent clinical signatures, informing earlier and more precise screening strategies.

1 February 2025 in JAMA Internal Medicine
Verified
Journal Article
Closed access
JKJerard Z. Kneifati-Hayek
Jerard Z. Kneifati-Hayek
MIMichael A. Incze
Michael A. Incze